A Lipid Mediator Hepoxilin A3 Is a Natural Inducer of Neutrophil Extracellular Traps in Human Neutrophils by Douda, David N. et al.
A Lipid Mediator Hepoxilin A3 Is
a Natural Inducer of Neutrophil
Extracellular Traps in Human Neutrophils
The Harvard community has made this
article openly available.  Please share  how
this access benefits you. Your story matters
Citation Douda, David N., Hartmut Grasemann, Cecil Pace-Asciak,
and Nades Palaniyar. 2015. “A Lipid Mediator Hepoxilin A3 Is
a Natural Inducer of Neutrophil Extracellular Traps in Human
Neutrophils.” Mediators of Inflammation 2015 (1): 520871.
doi:10.1155/2015/520871. http://dx.doi.org/10.1155/2015/520871.
Published Version doi:10.1155/2015/520871
Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:14351276
Terms of Use This article was downloaded from Harvard University’s DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at http://
nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAA
Research Article
A Lipid Mediator Hepoxilin A3 Is a Natural Inducer of
Neutrophil Extracellular Traps in Human Neutrophils
David N. Douda,1,2,3 Hartmut Grasemann,1,4,5 Cecil Pace-Asciak,1,6 and Nades Palaniyar1,2,5
1Lung Innate Immunity Research Laboratory, Program in Physiology & Experimental Medicine,
The Hospital for Sick Children Research Institute, Toronto, ON, Canada M5G 0A4
2Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, ON, Canada M5G 0A4
3Pulmonary & Critical Care Medicine Division, Brigham &Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA
4Division of Respiratory Medicine, Department of Paediatrics, The Hospital for Sick Children, Toronto, ON, Canada M5G 1X8
5Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada M5S 1A8
6Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada M5S 1A8
Correspondence should be addressed to Nades Palaniyar; nades.palaniyar@sickkids.ca
Received 6 November 2014; Accepted 12 January 2015
Academic Editor: Eduardo Lo´pez-Collazo
Copyright © 2015 David N. Douda et al.This is an open access article distributed under theCreativeCommonsAttribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Pulmonary exacerbations in cystic fibrosis airways are accompanied by inflammation, neutrophilia, andmucous thickening. Cystic
fibrosis sputum contains a large amount of uncleared DNA contributed by neutrophil extracellular trap (NET) formation from
neutrophils. The exact mechanisms of the induction of NETosis in cystic fibrosis airways remain unclear, especially in uninfected
lungs of patients with early cystic fibrosis lung disease. Here we show that Hepoxilin A3, a proinflammatory eicosanoid, and the
synthetic analog of Hepoxilin B3, PBT-3, directly induce NETosis in human neutrophils. Furthermore, we show that Hepoxilin
A3-mediated NETosis is NADPH-oxidase-dependent at lower doses of Hepoxilin A3, while it is NADPH-oxidase-independent
at higher doses. Together, these results demonstrate that Hepoxilin A3 is a previously unrecognized inducer of NETosis in cystic
fibrosis lungs and may represent a new therapeutic target for treating cystic fibrosis and other inflammatory lung diseases.
1. Introduction
In infected and inflamed tissues, recruited neutrophils release
neutrophil extracellular traps (NETs) [1]. NETs are made of
DNA, and the elaborate strings of DNA are decorated with
histones and antimicrobial proteins and peptides [2]. While
it was originally thought that NETs are an effective method
by which neutrophils trap and kill bacteria [3], a number
of studies now show the deleterious “side-effects” of NETs,
especially when overproduced [4].
It is now known that NETs directly cause host cell death
[5] and are directly linked to the pathogenesis of a number of
lung disorders including transfusion related acute lung injury
(TRALI) [6, 7], ventilator induced lung injury (VILI) [8],
pneumonia [9, 10], and cystic fibrosis (CF) [11]. However, the
precise mechanisms leading to the excess neutrophil recruit-
ment, activation, and NET production are not clearly under-
stood. Thus, the negative impact of NETs demonstrated in
a variety of inflammatory disorders illustrates the need to
better understand NETosis and its signaling pathways and
physiological mechanisms in regulating NETosis in health.
Hepoxilin A3 (HxA3) is a hydroxyepoxide derivative of
arachidonic acid [12] and is formed by a variety of tissues
through the 12-lipoxygenase/hepoxilin synthase pathways
[13]. A recent report shows that HxA3 is produced by epithe-
lial cells in response to bacterial infection [14]. Furthermore,
HxA3 is a chemoattractant that is necessary and sufficient
to recruit neutrophils to infected and inflamed sites [14, 15].
HxA3 causes the mobilization of intracellular calcium into
the cytosol in neutrophils [16]. The increase in intracellular
calcium causes activation of potassium current [17]. However,
it is not known whether HxA3 can activate neutrophils to
induce calcium dependent NETosis.
In this study, we sought to determine whether HxA3 can
directly induce NETosis. We show that HxA3 and PBT-3, a
synthetic analogue of HxB3, directly induce NETosis. These
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Figure 1: Hepoxilin A3 induces DNA release from human neutrophils. (a) Structure of HxA3. (b) Neutrophils were seeded into 96-well plates
in the presence or absence of HxA3, and the extracellular DNA release was monitored using Sytox Green cell impermeable DNA dye. The
results show a time-dependent increase in NET release after activation with HxA3 (10𝜇g/mL) (𝑛 = 4). HxA3 was used as the methyl ester.
results were confirmed by plate reader assays as well as by
immunofluorescence assays. Using DPI (20 𝜇M), a specific
inhibitor of NADPH oxidase (NOX), we also demonstrate
that HxA3-induced NETosis is NOX-dependent at lower
concentrations of HxA3 but becomes NOX-independent at
higher doses of HxA3.Therefore, HxA3 is a novel member of
natural lipid NET-inducers.
2. Materials and Methods
2.1. Reagents. All reagents were purchased from Sigma unless
otherwise stated.
2.2. Hepoxilin A3 and PBT-3. Both HxA3 and the Hx ana-
logue, PBT-3, were produced through total chemical synthe-
sis and used in this study as the methyl ester. HxA3 was pro-
vided by Corey and Su [18] and PBT-3 was synthesized in our
laboratory by Demin and Pace-Asciak [19]. Stock solutions
of the compounds were stored in benzene at −80∘C. When
required, aliquots were taken, the solvent was removed with
a stream of N2 gas, and the residue was dissolved in DMSO
at a concentration of 1 𝜇g/𝜇L for HxA3 and 2 𝜇g/𝜇L for PBT-3
and added to the cells.
2.3. Human Peripheral Neutrophils. Peripheral blood from
healthy donors was collected in K2 EDTA blood collection
tubes (BD, Franklin Lakes, NJ). A signed informed consent
was obtained fromeachdonor, and the protocolwas approved
by the Hospital for Sick Children ethics committee. Neu-
trophils were then isolated fromwhole blood using Polymor-
phPrep (Axis-Shield PoC, Oslo, Norway) according to the
manufacturer’s instructions with minor modifications. The
modifications are as follows: (i) the lysis of red blood cells
was done using a hypotonic saline solution (0.2% (w/v)NaCl)
and was followed by the addition of an equal volume of 1.6%
(w/v) NaCl solution with Hepes buffer (20mM, pH 7.2) to
make the solution buffered and isotonic.This was followed by
two washes with a wash buffer containing 0.85% (w/v) NaCl
and Hepes (10mM, pH 7.2). Isolated neutrophils were then
resuspended in RPMI (Invitrogen) supplemented withHepes
buffer (10mM, pH 7.2). In order to assess the requirement of
NADPHoxidase activity, neutrophils were preincubatedwith
NOX inhibitor diphenyleneiodonium (DPI) (20𝜇M) for 1 h
prior to the activation of cells for NETosis. For each experi-
ment, only 1-2 donor samples were processed each day. The
assays were repeated with different donors to obtain experi-
mental replicates.
2.4. Plate Reader Assay. For the plate reader assay, cells were
seeded at 3 × 104 cells per well in a 96-well plate in the culture
media in the presence of Sytox Green cell impermeable
nucleic acid stain (Life Technologies, Ontario, Canada) at
5 𝜇M. The fluorescence was measured using POLARstar
OMEGA fluorescence microplate reader (BMG Labtech,
Ortenberg, Germany) at specific time intervals for up to
240min. To calculate the relative release of NET DNA, flu-
orescence readout obtained from cells lysed with 0.5% (v/v)
Triton X-100 was considered as 100% DNA release, and the
release ofNETDNAat each time pointwas expressed as the%
of total release.
2.5. Confocal Imaging. For imaging, cells used for the plate
reader assay were fixed with PFA (4%, w/v) in PBS buffer
for 10min and permeablized with Triton X-100 (0.1%,
w/v). Mouse-𝛼-myeloperoxidase antibody (ab25989, Abcam,
Ontario, Canada) at 1 : 500 dilution and an anti-mouse IgG
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Figure 2: Hepoxilin A3 induces NETosis. Four hours after stimulation with either vehicle or HxA3, cells were fixed and stained for
immunofluorescence analysis. Cells were stained for DNA (green) and MPO (red) after activation with HxA3 (5𝜇g/mL). Images are
representative of 3 independent experiments.
secondary antibody conjugated with Alexa Fluor 555 (Invit-
rogen) were used for stainingMPO.DNAwas already stained
with Sytox Green for the plate reader assay. The confocal
images were taken using the Olympus IX81 inverted fluo-
rescence microscope equipped with a Hamamatsu C9100-
13 back-thinned EM-CCD camera and Yokogawa CSU X1
spinning disk confocal scan head (with Spectral Aurora Bore-
alis upgrade) and 4 separate diode-pumped solid state laser
lines (Spectral Applied Research, 405 nm, 491 nm, 561 nm,
and 642 nm).Theobjectives usedwere 20×/ 0.75 or 60×/ 1.35.
The microscope was operated with Volocity software (Perkin
Elmer, Waltham, MA). Images taken on the spinning disk
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Figure 3: PBT-3 induces DNA release from human neutrophils. (a) Structure of PBT-3. (b) Neutrophils were seeded into 96-well plates in
the presence or absence of PBT-3 (20𝜇g/mL), and the extracellular DNA release was monitored using Sytox Green cell impermeable DNA
dye. The results show a time-dependent increase in NET release after activation with PBT-3 (20𝜇g/mL) (𝑛 = 4). R = Methyl.
confocal microscope were deconvolved by iterative restora-
tion with confidence limit set to 95% and iteration limit set
to 20. All images were deconvolved to the confidence limit
before reaching iteration limit.
2.6. Statistical Analysis. All data are presented asmean± sem.
Statistical analysis was performed using GraphPad Prism sta-
tistical analysis software (Version 5.0a for Mac OS X). Where
appropriate, ANOVAwith Bonferroni post-hoc test was used.
A 𝑃 value which was set at 0.05 or less was considered to be
statistically significant.
3. Results and Discussion
3.1. Hepoxilin A3 Induces NETosis. A number of reports now
suggest pathogenic roles for NETs in lung disorders [6, 7].
NETs have been shown to be associated with transfusion-
related acute lung injury (TRALI) in an experimental mouse
model, as well as in humans by two independent groups
[6, 7]. In both of these studies, NETs were found to be present
in circulation and in lungs [6, 7], and therapeutic strategies
usingDNase [6, 7] or anti-histone antibody [6] to targetNETs
were found to be protective. The damaging effect of NETs is
thought to come directly from NETs, as it has been found
that NETs are capable of inflicting injury to epithelial and
endothelial cells [5, 20, 21].
Here we sought to determine whether HxA3 directly
induces NETosis in human neutrophils. HxA3 is an eicosan-
oid that acts as a lipid mediator of proinflammatory response
[12, 15, 16]. In addition, our group has shown that HxA3 acti-
vates neutrophils and induces the release of intracellular cal-
cium [16, 22]. Because calcium signaling is a critical compo-
nent of NETosis, we asked whether HxA3 is a natural inducer
of NETosis. The plate reader assays demonstrate a time-
dependent NET release in response to HxA3 (10 𝜇g/mL; 𝑃 <
0.001; Figure 1). Immunofluorescence imaging confirms that
HxA3 induces NET formation and release and that HxA3-
induced NETs contain myeloperoxidase (MPO) (Figure 2).
We next sought to confirm this finding by using PBT-3,
a synthetic analogue of HxB3 [13, 19]. As expected, the plate
reader assays demonstrate that NETs are released in response
to PBT-3 (Figure 3). The plate reader assays also show that
NET release by PBT-3 (20 𝜇g/mL) increases over time (𝑃 <
0.001); however, the extent of NET release was not as high
as that induced by HxA3 at 240min (Figure 1). This is not
unexpected as PBT-3 is an analog of HxB3 (notHxA3), which
is weak in releasing intracellular calcium from neutrophils.
This strongly suggests that calcium plays an important role in
mediating NETosis induced by HxA3. Immunofluorescence
assayswere then performed and confirmed that PBT-3 indeed
induces NETosis as evidenced by the colocalization of extra-
cellular DNA and MPO (Figure 4).
3.2. HxA3-Mediated NETosis Is Both NOX-Dependent and
NOX-Independent Depending on HxA3 Concentration. We
next asked whether HxA3-induced NETosis was NOX-
dependent. The plate reader assays show that, at lower
concentrations of HxA3 (2.5 and 5𝜇g/mL), DPI significantly
reduces NET release, suggesting that, at these concentrations,
ROS generation by NOX is required (Figure 5). At higher
concentrations of HxA3, there is less suppression of NETosis
by DPI (𝑃 < 0.05; Figure 5). At the highest concentration
tested (10 𝜇g/mL), HxA3-mediated NETosis completely over-
comes the suppression by DPI and becomes NOX-inde-
pendent (𝑃 < 0.001, Figure 5). These results suggest that
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Figure 4: PBT-3 induces NETosis. Four hours after stimulation with either vehicle or PBT-3 (20 𝜇g/mL), cells were fixed and stained for
immunofluorescence analysis. Cells were stained for DNA (green) and MPO (red) after activation with PBT-3 (20𝜇g/mL). Images are
representative of 3 independent experiments.
HxA3-mediated NETosis has both NOX-dependent and
NOX-independent features, conditioned by the HxA3 con-
centration.
Our group has shownpreviously thatHxA3 activates neu-
trophils by inducing a rise in intracellular calcium concentra-
tion [16]. Furthermore, we have shown that the activation of
neutrophils with HxA3 promotes the release of diacylglycerol
(DAG) in addition to increasing intracellular calcium [23],
pointing to the possibility that HxA3 activates PKC as well as
calcium signaling. Of the two distinct forms of NETosis (i.e.,
NOX-dependent and NOX-independent pathways), calcium
is indispensable in the NOX-independent pathway [24].
Furthermore, the activation of NOX-independent pathway in
neutrophils results in a rapid release of NETs (<1 h) compared
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Figure 5: Hepoxilin A3-mediated NETosis is both NOX-dependent
and NOX-independent depending on the dose of HxA3. A fluores-
cence plate reader assay was utilized to monitor NET DNA release
upon stimulation with HxA3 in the presence or absence of the NOX
inhibitor DPI (20 𝜇M) (𝑛 = 2; ∗𝑃 < 0.05; ∗∗∗𝑃 < 0.001 compared
to cells activated with HxA3 (2.5𝜇g/mL) in the presence of DPI
(DPI → 2.5); ##𝑃 < 0.01; ###𝑃 < 0.001 (one-way ANOVA)).
to theNOXdependent pathway (>2 h).Thus, it is possible that
NOX-dependent and NOX-independent NETosis are condi-
tioned by HxA3, whereby the activation of a specific pathway
depends on HxA3 concentration.
As mentioned above, NETs have been shown to be
involved in a number of inflammatory lung disorders [4].
Although some mechanistic insights have been obtained for
lung disorders such as TRALI, VILI, and pneumonia [6–10],
the precisemechanisms leading to abundantNETproduction
in other conditions such as CF remain elusive. It has been
shown thatNETs are found in airways of patientswithCF [11].
Bacterial pathogens such as Pseudomonas aeruginosa com-
monly infect CF airways. The overabundance of NET DNA
can support the biofilm formation by P. aeruginosa [25–27].
Because hepoxilins can be produced by epithelial cells in
response to P. aeruginosa infection [14], act as a chemoat-
tractant for neutrophils [14, 15, 28], and directly induce
NETosis (Figures 1 and 2), these compounds can be important
therapeutic targets for NET-associated lung disorders.
4. Conclusions
Thepresent study demonstrates that HxA3 can induceNETo-
sis in human neutrophils. The results were corroborated by
using PBT-3, a synthetic analogue of HxB3. The requirement
for ROS generation by NOX in HxA3-mediated NETosis is
dose-dependent, suggesting that HxA3 utilizes both NOX-
dependent and NOX-independent pathways. Our finding
thatHxA3directly inducesNETosis suggests thatHxA3 could
induce NETosis in the lung, and hepoxilins and members of
hepoxilin-generating pathways may therefore be therapeutic
targets in NETs related inflammatory lung disorders.
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